RKIP is typically downregulated in most cancers [8–10] and functions as a metastasis suppressor [11], immune inducer [12], inhibitor of cancer cell viability and proliferation [13], and a sensitizer to reverse therapeutic resistance [14]. The gene discussed is PEBP1; the disease is cancer.